| Year |
Citation |
Score |
| 2023 |
Castro Eiro MD, Hioki K, Li L, Wilmsen MEP, Kiernan CH, Brouwers-Haspels I, van Meurs M, Zhao M, de Wit H, Grashof DGB, van de Werken HJG, Mueller YM, Schliehe C, Temizoz B, Kobiyama K, et al. TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model. Journal of Immunology (Baltimore, Md. : 1950). PMID 38063488 DOI: 10.4049/jimmunol.2300038 |
0.757 |
|
| 2023 |
Li L, Zhao M, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Wilmsen MEP, Grashof DGB, van de Werken HJG, Hendriks RW, Mueller YM, Katsikis PD. Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK. Frontiers in Immunology. 14: 1201415. PMID 37771591 DOI: 10.3389/fimmu.2023.1201415 |
0.79 |
|
| 2023 |
Zhao M, Li L, Kiernan CH, Castro Eiro MD, Dammeijer F, van Meurs M, Brouwers-Haspels I, Wilmsen MEP, Grashof DGB, van de Werken HJG, Hendriks RW, Aerts JG, Mueller YM, Katsikis PD. Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition. Scientific Reports. 13: 15678. PMID 37735204 DOI: 10.1038/s41598-023-42871-y |
0.777 |
|
| 2022 |
Mueller YM, Schrama TJ, Ruijten R, Schreurs MWJ, Grashof DGB, van de Werken HJG, Lasinio GJ, Álvarez-Sierra D, Kiernan CH, Castro Eiro MD, van Meurs M, Brouwers-Haspels I, Zhao M, Li L, de Wit H, et al. Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning. Nature Communications. 13: 915. PMID 35177626 DOI: 10.1038/s41467-022-28621-0 |
0.704 |
|
| 2022 |
Hope JL, Zhao M, Stairiker CJ, Kiernan CH, Carey AJ, Mueller YM, van Meurs M, Brouwers-Haspels I, Otero DC, Bae EA, Faso HA, Maas A, de Looper H, Fortina PM, Rigoutsos I, et al. MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8 T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). 208: 603-617. PMID 35022277 DOI: 10.4049/jimmunol.2000621 |
0.652 |
|
| 2020 |
Zhao M, Kiernan CH, Stairiker CJ, Hope JL, Leon LG, van Meurs M, Brouwers-Haspels I, Boers R, Boers J, Gribnau J, van IJcken WFJ, Bindels EM, Hoogenboezem RM, Erkeland SJ, Mueller YM, et al. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation. Plos Pathogens. 16: e1008555. PMID 32579593 DOI: 10.1371/Journal.Ppat.1008555 |
0.671 |
|
| 2020 |
Kiernan CH, Asmawidjaja PS, Fahy N, Witte-Bouma J, Wolvius EB, Brama PAJ, Lubberts E, Farrell. Allogeneic Chondrogenic Mesenchymal Stromal Cells Alter Helper T Cell Subsets in CD4+ Memory T Cells. Tissue Engineering. Part A. 26: 490-502. PMID 31797740 DOI: 10.1089/ten.TEA.2019.0177 |
0.43 |
|
| 2019 |
Hope JL, Spantidea PI, Kiernan CH, Stairiker CJ, Rijsbergen LC, van Meurs M, Brouwers-Haspels I, Mueller YM, Nelson DJ, Bradley LM, Aerts JGJV, Katsikis PD. Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model. Frontiers in Immunology. 10: 3074. PMID 31998326 DOI: 10.3389/Fimmu.2019.03074 |
0.72 |
|
| 2016 |
Kiernan CH, Hoogduijn MJ, Franquesa M, Wolvius EB, Brama PAJ, Farrell E. Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro. Cytotherapy. 18: 957-969. PMID 27288309 DOI: 10.1016/j.jcyt.2016.05.002 |
0.408 |
|
| Show low-probability matches. |